Concepedia

Clayton Hardman

CH

5

Publications

225

Citations

5

H-Index

2017

Active since

Affiliations

Stanford University(Current)

University of California, Los Angeles

Clayton Hardman is an author at Stanford University specializing in immunology, cell biology, and medicine.

ORCID

Top concepts

Publications per year

2017–2021

5

Publications

5

Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV

Paul A. Wender, Clayton Hardman, Stephen Ho et al. · Science · 2017 · 103 citations · Full text

Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy

Clayton Hardman, Stephen Ho, Akira Shimizu et al. · Nature Communications · 2020 · 51 citations · Full text

, , +19

Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents

Matthew D. Marsden, Xiaomeng Wu, Sara M. Navab et al. · Virology · 2018 · 41 citations · Full text

Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation

Efrat Abramson, Clayton Hardman, Akira Shimizu et al. · Cell chemical biology · 2021 · 19 citations · Full text

, , +6

Function-Oriented Synthesis: Design, Synthesis, and Evaluation of Highly Simplified Bryostatin Analogues

Paul A. Wender, Jack L. Sloane, Quang H. Luu-Nguyen et al. · The Journal of Organic Chemistry · 2020 · 11 citations

Rows per page

1–5 of 5